Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

HIV-1-infected patients vary considerably by their response to antiretroviral treatment, drug concentrations in plasma, toxic events, and rate of immune recovery. This variability could have a genetic basis. We did a pharmacogenetics study to analyse the association between response to antiretroviral treatment and allelic variants of several genes.


Published in:
Lancet, 359, 9300, 30-6
Year:
2002
Publisher:
Elsevier
ISSN:
0140-6736
Keywords:
Note:
Comment in: Lancet. 2002 Jun 15;359(9323):2114; author reply 2214-5.
Laboratories:




 Record created 2011-04-15, last modified 2018-03-17


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)